Thermo Fisher Scientific Inc. (TMO) has priced an offering of 2.1 billion euros aggregate principal amount of euro-denominated notes, to be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly owned finance subsidiary. The offering consists of 1.0 billion euros floating rate senior notes due 2027 and 1.1 billion euros 3.628% senior notes due 2035, each issued at 100.000% of their principal amount.
The offering is expected to close on or about December 1, 2025.
Thermo Fisher said it intends to use the net proceeds from the sale of the notes for general corporate purposes, which may include the acquisition of companies or businesses, repayment and refinancing of debt, working capital and capital expenditures or the repurchase of its outstanding equity securities, or it may temporarily invest the net proceeds in short-term, liquid investments until they are used for their ultimate purpose.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.